KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Vir Biotechnology (VIR) Gross Margin (2021 - 2025)

Historic Gross Margin for Vir Biotechnology (VIR) over the last 6 years, with Q2 2025 value amounting to 99.09%.

  • Vir Biotechnology's Gross Margin rose 7800.0% to 99.09% in Q2 2025 from the same period last year, while for Jun 2025 it was 96.08%, marking a year-over-year decrease of 27200.0%. This contributed to the annual value of 98.86% for FY2024, which is 20700.0% up from last year.
  • According to the latest figures from Q2 2025, Vir Biotechnology's Gross Margin is 99.09%, which was up 7800.0% from 100.0% recorded in Q1 2025.
  • Over the past 5 years, Vir Biotechnology's Gross Margin peaked at 100.0% during Q1 2021, and registered a low of 31.28% during Q2 2022.
  • For the 5-year period, Vir Biotechnology's Gross Margin averaged around 92.81%, with its median value being 97.44% (2024).
  • As far as peak fluctuations go, Vir Biotechnology's Gross Margin plummeted by -680400bps in 2022, and later soared by 681400bps in 2023.
  • Over the past 5 years, Vir Biotechnology's Gross Margin (Quarter) stood at 93.0% in 2021, then fell by -6bps to 87.86% in 2022, then increased by 8bps to 95.25% in 2023, then fell by -1bps to 94.47% in 2024, then grew by 5bps to 99.09% in 2025.
  • Its last three reported values are 99.09% in Q2 2025, 100.0% for Q1 2025, and 94.47% during Q4 2024.